These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20046154)

  • 1. Estimation of antiretroviral therapy coverage: methodology and trends.
    Mahy M; Tassie JM; Ghys PD; Stover J; Beusenberg M; Akwara P; Souteyrand Y
    Curr Opin HIV AIDS; 2010 Jan; 5(1):97-102. PubMed ID: 20046154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human resources for treating HIV/AIDS: needs, capacities, and gaps.
    Bärnighausen T; Bloom DE; Humair S
    AIDS Patient Care STDS; 2007 Nov; 21(11):799-812. PubMed ID: 17944556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage.
    Boerma JT; Stanecki KA; Newell ML; Luo C; Beusenberg M; Garnett GP; Little K; Calleja JG; Crowley S; Kim JY; Zaniewski E; Walker N; Stover J; Ghys PD
    Bull World Health Organ; 2006 Feb; 84(2):145-50. PubMed ID: 16501733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV testing coverage of family members of adult antiretroviral therapy patients in Malawi.
    Cohen D; Lungu M; van Oosterhout JJ
    AIDS Care; 2010 Nov; 22(11):1346-9. PubMed ID: 20635242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
    Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
    Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008.
    Galárraga O; O'Brien ME; Gutiérrez JP; Renaud-Théry F; Nguimfack BD; Beusenberg M; Waldman K; Soni A; Bertozzi SM; Greener R
    AIDS; 2007 Jul; 21 Suppl 4():S97-103. PubMed ID: 17620759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").
    Aceijas C; Oppenheimer E; Stimson GV; Ashcroft RE; Matic S; Hickman M
    Addiction; 2006 Sep; 101(9):1246-53. PubMed ID: 16911723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens.
    Renaud-Théry F; Nguimfack BD; Vitoria M; Lee E; Graaff P; Samb B; Perriëns J
    AIDS; 2007 Jul; 21 Suppl 4():S89-95. PubMed ID: 17620758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early versus deferred antiretroviral therapy in children in low-income and middle-income countries.
    Puthanakit T; Bunupuradah T
    Curr Opin HIV AIDS; 2010 Jan; 5(1):12-7. PubMed ID: 20046143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of HIV-infected children with tuberculosis who are started on antiretroviral therapy in Malawi.
    Bong CN; Chen SC; Jong YJ; Tok TS; Hsu CF; Schouten EJ; Makombe SD; Yu JK; Harries AD
    Int J Tuberc Lung Dis; 2007 May; 11(5):534-8. PubMed ID: 17439677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequencing of antiretroviral therapy in children in low- and middle-income countries.
    Sohn AH; Nuttall JJ; Zhang F
    Curr Opin HIV AIDS; 2010 Jan; 5(1):54-60. PubMed ID: 20046148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy for children in the routine setting in Malawi.
    Malawi Paediatric Antiretroviral Treatment Group
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):511-6. PubMed ID: 17197006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PENTA guidelines for the use of antiretroviral therapy, 2004.
    Sharland M; Blanche S; Castelli G; Ramos J; Gibb DM;
    HIV Med; 2004 Jul; 5 Suppl 2():61-86. PubMed ID: 15239717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities.
    Nachega JB; Mills EJ; Schechter M
    Curr Opin HIV AIDS; 2010 Jan; 5(1):70-7. PubMed ID: 20046150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.